Catalio Capital Management
Stan Lapidus is an experienced leader in the diagnostics and healthcare sectors, currently serving as Chairman of the Board for multiple companies, including Mercy BioAnalytics, binx health, Mirvie, and Lucid Diagnostics, where Stan focuses on innovative solutions for early cancer detection and medical testing. Additional board roles include membership at Droplet Biosciences, PathAI, and Sunbird Bio, contributing to advancements in predictive diagnostics and machine learning applications in healthcare. With a background in Electrical Engineering from The Cooper Union and extensive involvement in venture capital as a founding member of Pillar VC, Stan Lapidus also holds an Executive in Residence position at the University of Colorado Anschutz Medical Campus and manages Lapidx Research, a personal incubator for novel medical technologies.
This person is not in any teams
This person is not in any offices
Catalio Capital Management
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, serial scientist-entrepreneurs.